GTG 9.09% 1.2¢ genetic technologies limited

Pfizer taker over?

  1. 1,372 Posts.
    http://sierraworldequityreview.blogspot.com.au/2015/02/pfizer-pfe-to-acquire-genetic.html

    Pfizer (PFE) To Acquire Genetic Technologies (GENE) Following Ibrance FDA Approval For ER-Positive, HER2-negative Breast Cancer Predicts Sierra Equity
    Latest Projections: Pfizer (PFE) To Acquire Genetic Technologies (GENE) Following Ibrance FDA Approval For ER-Positive, HER2-negative Breast Cancer Predicts Sierra Equity. Look for the share price of GENE to start moving higher as potential buyout talks happen in NYC this month forecasts Sierra. Check back as Sierra follows her leads! Look for the official news coming, when it breaks remember Sierra called this first!
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
1.2¢
Change
0.00(9.09%)
Mkt cap $30.52M
Open High Low Value Volume
1.2¢ 1.2¢ 1.1¢ $176.0K 14.67M

Buyers (Bids)

No. Vol. Price($)
27 4726753 1.1¢
 

Sellers (Offers)

Price($) Vol. No.
1.2¢ 3312707 3
Last update - 16.10pm 19/10/2018 (20 minute delay) ?
(live)
Last
1.2¢
  Change
0.00 ( 0.00 %)
Open High   Low Volume
1.2¢ 1.2¢   1.2¢ 4148866
Last updated 15.59pm 19/10/2018 (live) ?
GTG (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.